NCT06267261View on ClinicalTrials.gov

Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

August 23, 2021

Study Completion Date

October 25, 2021

Conditions
Allergic AsthmaAllergic Rhinitis
Interventions
DEVICE

KOLMI® surgical face mask (OP-Air)

12 subjects are exposed to birch pollen allergen in ALYATEC EEC while wearing a KOLMI® surgical face mask (OP-Air)

Trial Locations (1)

Unknown

ALYATEC, Strasbourg

Sponsors

Lead Sponsor

Alyatec

Collaborators (1)

Medicom
All Listed Sponsors
collaborator

Medicom

UNKNOWN

lead

Alyatec

INDUSTRY

NCT06267261 - Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber | Biotech Hunter | Biotech Hunter